13.71 USD
▲+0.08+0.96%
盘后 13.53 -0.41%
2026-08-03
市值
$788.61M
市盈率
—
EPS
-0.60
股息率
—
52 周区间
8.67 – 26.19
成交量
330.46K
Beta
-0.21
目标价
41.10
52W 低 8.6752W 高 26.19
价格走势
公司简介
DBV Technologies S.A., a clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France. Its product pipeline comprising Viaskin Peanut, an immunotherapy product, which has completed Phase 3 clinical trial for the treatment of peanut allergies; and Viaskin Milk which is in Phase 1/2 clinical trial for the treatment of immunoglobulin E (IgE) mediated or cow’s milk protein allergy and eosinophilic esophagitis. The company’s earlier stage research programs include celiac disease. ...